InvestorsHub Logo
Followers 24
Posts 2301
Boards Moderated 0
Alias Born 03/18/2013

Re: HDGabor post# 52243

Tuesday, 06/23/2015 6:05:28 PM

Tuesday, June 23, 2015 6:05:28 PM

Post# of 429352
HD: There was a PR issued today @ 8:08 am.
8:08 am Amarin will present new in vitro eicosapentaenoic acid study data; found that EPA reduced cholesterol crystalline domain levels in cholesterol-enriched model membranes by 65% (AMRN) : "The purpose of the study was to examine whether EPA, under atherosclerotic-like conditions, can reduce the formation of cholesterol crystalline domains. Our research team found that EPA reduced cholesterol crystalline domain levels in cholesterol-enriched model membranes by 65%...... That's all I could see to capture.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News